Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Chiesi Reports Strong FY2025 Financial and Sustainability Results and Announces Leadership Transition Highlights

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Biotechnology
Professional Services
Health
Pharmaceutical
Research
Genetics
Environment
Science
Clinical Trials
Finance
Sustainability
Strong FY2025 Financial and Sustainability Results

More Like This

Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets

Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges

Business Wire logo

For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025

Business Wire logo

Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress

Business Wire logo

Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance

Business Wire logo

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us